• Home
  • Patients
    • Causes
    • Symptoms
    • Diagnosis
    • Treatment
    • Patient Stories
  • Providers
    • Indications & Patient Selection
    • Procedure and Mode of Action
    • Heart Failure Resources
    • Reimbursement
    • Instructions for Use and Product Manuals
  • Our Science
    • Clinical Studies
      • Aim Higher Study
      • Integra-D
    • Publications
  • Company
    • Executive Team
    • News Center
    • Safety Information
    • Ethics & Compliance
    • Grants & Donations
    • Careers
    • Contact Us
  • Find A Provider
  • REGION
    • North America
      • United States
      • Pacific
      • Australia
      • New Zeland
    • Pacific
      • Australia
      • New Zeland
    • Europe
      • Austria
      • Belgium
      • Czech Republic
      • Denmark
      • Finland
      • France
    • Europe
      • Germany
      • Hungary
      • Ireland
      • Italy
      • Netherlands
      • Norway
    • Europe
      • Poland
      • Portugal
      • Spain
      • Sweden
  • Home
  • Patients
    • Causes
    • Symptoms
    • Diagnosis
    • Treatment
    • Patient Stories
  • Providers
    • Indications & Patient Selection
    • Procedure and Mode of Action
    • Heart Failure Resources
    • Reimbursement
    • Instructions for Use and Product Manuals
  • Our Science
    • Clinical Studies
      • Aim Higher Study
      • Integra-D
    • Publications
  • Company
    • Executive Team
    • News Center
    • Safety Information
    • Ethics & Compliance
    • Grants & Donations
    • Careers
    • Contact Us
  • Find A Provider
  • REGION
    • North America
      • United States
      • Pacific
      • Australia
      • New Zeland
    • Pacific
      • Australia
      • New Zeland
    • Europe
      • Austria
      • Belgium
      • Czech Republic
      • Denmark
      • Finland
      • France
    • Europe
      • Germany
      • Hungary
      • Ireland
      • Italy
      • Netherlands
      • Norway
    • Europe
      • Poland
      • Portugal
      • Spain
      • Sweden

IMPULSE DYNAMICS’ QUALITY MANAGEMENT SYSTEM RECEIVES CERTIFICATION UNDER EUROPEAN UNION MEDICAL DEVICE REGULATION

by Impulse Dynamics | Mar 22, 2022 | News and Events, Press Releases

PRESS RELEASE Impulse Dynamics Is Now Among the First US-based Manufacturers of Active Implantable Devices To Receive Certification MARLTON, N.J., March 22, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a company dedicated to innovative treatments for chronic heart...

IMPULSE DYNAMICS ANNOUNCES FIRST PATIENT ENROLLED IN AIM HIGHer — IMPLANTABLE DEVICE TRIAL TO TREAT HEART FAILURE IN HIGHER EF POPULATION

by Impulse Dynamics | Mar 14, 2022 | News and Events, Press Releases

PRESS RELEASE Trial Evaluates FDA-Designated BreakthroughTherapy for Patients Who Lack Treatment Options MARLTON, N.J., March 14, 2022 — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today...

Recent Posts

  • Impulse Dynamics Announces 100th Implant Milestone in China for CCM® Therapy
  • SynPost IT
  • Sync Global IT DE
  • test sync Global
  • TEST SYNC POST MM de

Recent Comments

    Archives

    • November 2022
    • August 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • January 2022
    • November 2021
    • October 2021
    • July 2021
    • February 2021
    • January 2021
    • April 2020
    • March 2020
    • December 2019
    • November 2019
    • October 2019
    • July 2019
    • March 2019
    • May 2018
    • December 2017
    • August 2017
    • May 2017
    • March 2017
    • September 2016
    • May 2016
    • March 2016
    • January 2016
    • November 2015
    • August 2015
    • July 2015
    • January 2015
    • December 2014

    Categories

    • News and Events
    • Press Releases
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org